NEWRON

Serial Number 88254077
Registration 5975094
700

Registration Progress

Application Filed
Jan 8, 2019
Under Examination
Approved for Publication
Nov 19, 2019
Published for Opposition
Nov 19, 2019
Registered
Feb 4, 2020

Attorney Assistance

Section 8 Declaration Due (Principal Register) (Based on registration date 20200204)
Due: Feb 04, 2026 37 days

Trademark Image

NEWRON

Basic Information

Serial Number
88254077
Registration Number
5975094
Filing Date
January 8, 2019
Registration Date
February 4, 2020
Published for Opposition
November 19, 2019
Drawing Code
4

Status Summary

Current Status
Active
Status Code
700
Status Date
Feb 4, 2020
Registration
Registered
Classes
001 005 042 044

Rights Holder

NEWRON PHARMACEUTICALS S.p.A.

99
Address
Via L. Ariosto, 21
Bresso (MI) I-20091
IT

Ownership History

NEWRON PHARMACEUTICALS S.p.A.

Original Applicant
99
Bresso (MI) IT

NEWRON PHARMACEUTICALS S.p.A.

Owner at Publication
99
Bresso (MI) IT

NEWRON PHARMACEUTICALS S.p.A.

Original Registrant
99
Bresso (MI) IT

Legal Representation

Attorney
Anthony P. Venturino

USPTO Deadlines

Next Deadline
37 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20200204)
Due Date
February 04, 2026
Grace Period Ends
August 04, 2026
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

16 events
Date Code Type Description Documents
Feb 4, 2025 REM1 E COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED Loading...
Feb 4, 2020 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 19, 2019 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 19, 2019 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 30, 2019 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 16, 2019 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 15, 2019 ALIE A ASSIGNED TO LIE Loading...
Mar 26, 2019 GNS3 O NOTIFICATION OF LETTER OF SUSPENSION E-MAILED Loading...
Mar 26, 2019 GNSL S LETTER OF SUSPENSION E-MAILED Loading...
Mar 26, 2019 CNSL R SUSPENSION LETTER WRITTEN Loading...
Mar 25, 2019 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Mar 25, 2019 GNRT F NON-FINAL ACTION E-MAILED Loading...
Mar 25, 2019 CNRT R NON-FINAL ACTION WRITTEN Loading...
Mar 23, 2019 DOCK D ASSIGNED TO EXAMINER Loading...
Jan 29, 2019 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jan 11, 2019 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 001
Biochemicals, namely, precursors for in vitro genetic engineering use, biochemicals, namely, polypeptides for in vitro research use, biochemicals, namely, monoclonal antibodies for in vitro scientific or research use, genetic identity tests comprised of reagents for scientific or research use, reagents for scientific or medical research use
Class 005
Pharmaceutical and veterinary preparations, namely, vaccines for animal and human use, pharmaceutical preparations for the treatment of respiratory infections, eye infections, arthritis and anxiety; and medical diagnostic reagents for clinical or medical laboratory use
Class 042
Product research, chemical research, medical research
Class 044
Medical services, medical services, namely, in vitro fertilization, medical analysis services

Classification

International Classes
001 005 042 044